Insulin-like growth factor binding protein-5 in osteogenesis: Facilitator or inhibitor?

Aditi Mukherjee, Peter Rotwein

Research output: Contribution to journalReview articlepeer-review

28 Scopus citations


The insulin-like growth factors (IGFs) play a central role in controlling somatic growth in mammals and exert anabolic effects on most tissues, including bone. IGF action is mediated by the IGF-I receptor and additionally is regulated by six high-affinity IGF binding proteins (IGFBP-1 through IGFBP-6), of which IGFBP-4 and IGFBP-5 are most abundant in bone. The focus of this brief review is on the role of IGFBP-5 in bone biology. IGFBP-5 has been implicated as a pro-osteogenic factor in several studies but conversely has been shown to act as an inhibitor of bone formation, primarily by interfering with IGF actions on osteoblasts. These potentially contradictory effects of IGFBP-5 in bone are further complicated by observations indicating that IGFBP-5 additionally may function in an IGF-independent way, and may have been accentuated by differences in both experimental design and methodology among published studies. Suggestions are made for a more systematic approach to help discern the true roles of IGFBP-5 in bone physiology.

Original languageEnglish (US)
Pages (from-to)179-185
Number of pages7
JournalGrowth Hormone and IGF Research
Issue number3
StatePublished - Jun 2007
Externally publishedYes

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology


Dive into the research topics of 'Insulin-like growth factor binding protein-5 in osteogenesis: Facilitator or inhibitor?'. Together they form a unique fingerprint.

Cite this